DK403587D0 - Acetyl-l-carnitin til anvendelse til behandling af perifere neuropathier - Google Patents

Acetyl-l-carnitin til anvendelse til behandling af perifere neuropathier

Info

Publication number
DK403587D0
DK403587D0 DK403587A DK403587A DK403587D0 DK 403587 D0 DK403587 D0 DK 403587D0 DK 403587 A DK403587 A DK 403587A DK 403587 A DK403587 A DK 403587A DK 403587 D0 DK403587 D0 DK 403587D0
Authority
DK
Denmark
Prior art keywords
carnitine
acetyl
treatment
peripheral neuropathies
symptomatological
Prior art date
Application number
DK403587A
Other languages
English (en)
Other versions
DK164641C (da
DK164641B (da
DK403587A (da
Inventor
Menotti Calvani
Luigi Mosconi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of DK403587D0 publication Critical patent/DK403587D0/da
Publication of DK403587A publication Critical patent/DK403587A/da
Publication of DK164641B publication Critical patent/DK164641B/da
Application granted granted Critical
Publication of DK164641C publication Critical patent/DK164641C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK403587A 1986-08-04 1987-08-03 Anvendelse af acetyl-l-carnitin og farmaologisk acceptable salte deraf til fremstilling af laegemidler til behandling af perifere neuropathier DK164641C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48358/86A IT1196564B (it) 1986-08-04 1986-08-04 Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
IT4835886 1986-08-04

Publications (4)

Publication Number Publication Date
DK403587D0 true DK403587D0 (da) 1987-08-03
DK403587A DK403587A (da) 1988-02-05
DK164641B DK164641B (da) 1992-07-27
DK164641C DK164641C (da) 1992-12-14

Family

ID=11266089

Family Applications (1)

Application Number Title Priority Date Filing Date
DK403587A DK164641C (da) 1986-08-04 1987-08-03 Anvendelse af acetyl-l-carnitin og farmaologisk acceptable salte deraf til fremstilling af laegemidler til behandling af perifere neuropathier

Country Status (11)

Country Link
US (1) US4751242A (da)
EP (1) EP0256999B1 (da)
JP (1) JPH085786B2 (da)
AT (1) ATE70439T1 (da)
CA (1) CA1298197C (da)
DE (1) DE3775301D1 (da)
DK (1) DK164641C (da)
ES (1) ES2039262T3 (da)
GR (1) GR3003405T3 (da)
IT (1) IT1196564B (da)
ZA (1) ZA875643B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
US5641764A (en) * 1989-03-31 1997-06-24 Peter Maccallum Institute Halogenated DNA ligand radiosensitizers for cancer therapy
IT1230141B (it) * 1989-05-03 1991-10-14 Fidia Spa Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
IT1244636B (it) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT1245699B (it) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
JPH11298323A (ja) 1998-04-16 1999-10-29 Nec Yamagata Ltd 高速ロックアップｐｌｌ回路
KR100645980B1 (ko) * 1998-07-30 2006-11-14 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 항암 활성을 갖는 약제의 제조에서 ｌ-카르니틴 및 그의알카노일 유도체의 용도
US20030199535A1 (en) * 1998-07-30 2003-10-23 Claudio Cavazza Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
AU7828200A (en) * 1999-09-23 2001-04-24 Juvenon Corporation Nutritional supplement for increased energy and stamina
US6562869B1 (en) * 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
ITRM20010293A1 (it) * 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
ITRM20010294A1 (it) * 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil l-carnetina in associazione con la biotina per il trattamento di pazienti affetti da diabete mellito di tipo ii insulino re
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
ITRM20040327A1 (it) * 2004-07-01 2004-10-01 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici.
US8569366B2 (en) * 2005-04-26 2013-10-29 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Acetyl L-carnitine for prevention of painful peripheral neuropathy in patients with type 2 diabetes
DK1874288T3 (da) * 2005-04-26 2013-08-26 Sigma Tau Ind Farmaceuti Acetyl L-carnitin til forebyggelse af smertefuld, perifer diabetisk neuropati
US20080161604A1 (en) * 2005-04-26 2008-07-03 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Acetyl L-Carnitine For Preventing Painful Peripheral Diabetic Neuropathy
JP2006347935A (ja) * 2005-06-15 2006-12-28 Masanori Ogata 炎症性サイトカインの産生が関与する疾患の予防及び／又は治療のための医薬
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
SG185692A1 (en) 2010-06-16 2013-01-30 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
US10413526B2 (en) 2015-03-31 2019-09-17 Kolinpharma S.P.A. Composition for the treatment of neuropathies and/or neuropathic pain
US10036011B2 (en) * 2016-02-11 2018-07-31 Qiagen Waltham, Inc. Scavenger compounds for improved sequencing-by-synthesis
EP4149437A1 (en) 2020-05-15 2023-03-22 Alfasigma S.p.A. Composition comprising methylfolate
EP4364730A1 (en) 2022-11-02 2024-05-08 Chiesi Italia S.p.A. Pharmaceutical composition comprising l-acetyl carnitine and beta-caryophyllene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
IT1196564B (it) 1988-11-16
US4751242A (en) 1988-06-14
DK164641C (da) 1992-12-14
EP0256999B1 (en) 1991-12-18
ATE70439T1 (de) 1992-01-15
JPS6344522A (ja) 1988-02-25
DK164641B (da) 1992-07-27
DE3775301D1 (de) 1992-01-30
EP0256999A3 (en) 1989-05-31
CA1298197C (en) 1992-03-31
ES2039262T3 (es) 1993-09-16
ZA875643B (en) 1988-11-30
EP0256999A2 (en) 1988-02-24
IT8648358A0 (it) 1986-08-04
GR3003405T3 (en) 1993-02-17
JPH085786B2 (ja) 1996-01-24
DK403587A (da) 1988-02-05

Similar Documents

Publication Publication Date Title
DK403587D0 (da) Acetyl-l-carnitin til anvendelse til behandling af perifere neuropathier
DE3773442D1 (de) Dosierungsform zur verabreichung eines medikaments mit mitteln zur regelung der loeslichkeit.
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
DK275488A (da) Indolonderivater
FI942504A0 (fi) N,N'-diasetyylikystiinin orgaanisia suoloja
MY101207A (en) Treatment of diseases caused by retroviruses
RU94027569A (ru) Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения
DE3768419D1 (de) Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
DK207889D0 (da) Farmaceutisk praeparat med anti-cancer virkning
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
ATE97001T1 (de) Topisch anzuwendende defibrotid enthaltende arzneizubereitungen.
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
NO885100D0 (no) Anvendelse av 1,3-butandiolacetoacetat som nŸringsmiddel, sŸrlig for parenteral tilfsel.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
IT1224250B (it) Associzione del depiprazolo con la morfina
DK447387A (da) Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
IT1209519B (it) Composti ad attivita'cardiotrofica.
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
DE3889417D1 (de) Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln.
GR3004333T3 (da)
ATE92466T1 (de) Verwendung eines spermin-derivats mit antineoplastischer wirkung zur herstellung pharmazeutischer zusammensetzungen.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
RU94020401A (ru) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ β -ФЕНИЛ-ИЗОСЕРИНА И ПРОИЗВОДНЫЕ b -ФЕНИЛ-ИЗОСЕРИНА

Legal Events

Date Code Title Description
PUP Patent expired